Compare Moderna, Inc. (MRNA) vs S&P500 ETF (SPY) Price & Performance

Moderna, Inc.Trade

S&P500 ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs S&P500 ETF — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while S&P500 ETF trades at $747.94. The key difference: S&P500 ETF is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

	MRNA	SPY
Market Cap	$23.60B	—
Sector	Health	—
52-Week High	$81.80	$759.55
52-Week Low	$22.36	$621.75
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

SPY

Vanguard's VEA ETF offers low-cost developed market exposure beyond the U.S., balancing diversification and risk.24/7 Wall Street · 7 hours agoNeutral John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 14 hours agoBullish XLK ETF hides high concentration risk in top tech stocks despite low fees.24/7 Wall Street · 1 day agoNeutral View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.